Delphine Ciron-Larrieu
Toulouse, 31100, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
BRAF and MEK inhibitor targeted therapy in papillary craniopharyngiomas: a cohort study.
Journal: European journal of endocrinology
Published: April 17, 2024
T2-Fluid-attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone.
Journal: European journal of neurology
Published: February 27, 2023
Hypofractionated Stereotactic Re-irradiation and Anti-PDL1 Durvalumab Combination in Recurrent Glioblastoma: STERIMGLI Phase I Results.
Journal: The oncologist
Published: December 15, 2022
CNS tumor with EP300::BCOR fusion: discussing its prevalence in adult population.
Journal: Acta neuropathologica communications
Published: December 09, 2022
Real-life efficacy and predictors of response to immunotherapy in pituitary tumors: a cohort study.
Journal: European journal of endocrinology
Published: July 28, 2022
Pediatric spinal pilocytic astrocytomas form a distinct epigenetic subclass from pilocytic astrocytomas of other locations and diffuse leptomeningeal glioneuronal tumours.
Journal: Acta neuropathologica
Published: May 07, 2022
Chemotherapy is an efficient treatment in primary CNS MALT lymphoma.
Journal: Journal of neuro-oncology
Published: April 29, 2022
Adult brainstem glioma differential diagnoses: an MRI-based approach in a series of 68 patients.
Journal: Journal of neurology
Published: November 18, 2021
A prospective behavioral and imaging study exploring the impact on long-term memory of radiotherapy delivered for a brain tumor in childhood and adolescence.
Journal: Clinical and translational radiation oncology
Published: June 23, 2021
Life-threatening complications after high-dose methotrexate and the benefits of glucarpidase as salvage therapy: a cohort study of 468 patients.
Journal: Leukemia & lymphoma
Published: November 12, 2020
The EP300:BCOR fusion extends the genetic alteration spectrum defining the new tumoral entity of "CNS tumors with BCOR internal tandem duplication".
Journal: Acta neuropathologica communications
Published: September 29, 2020
Last Updated: 09/26/2026